Marotta Asset Management Grows Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Marotta Asset Management raised its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,196 shares of the exchange traded fund’s stock after buying an additional 1,266 shares during the period. SPDR S&P Biotech ETF comprises about 1.2% of Marotta Asset Management’s holdings, making the stock its 24th largest position. Marotta Asset Management owned 0.08% of SPDR S&P Biotech ETF worth $5,784,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of XBI. Healthcare of Ontario Pension Plan Trust Fund grew its position in SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $141,284,000. Affinity Asset Advisors LLC grew its stake in shares of SPDR S&P Biotech ETF by 105.4% in the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock valued at $3,481,000 after purchasing an additional 737,550 shares during the last quarter. Assetmark Inc. raised its stake in shares of SPDR S&P Biotech ETF by 72,653.0% during the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after purchasing an additional 588,489 shares during the last quarter. Finally, Sivik Global Healthcare LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $29,640,000.

SPDR S&P Biotech ETF Stock Down 3.0 %

Shares of NYSEARCA XBI traded down $2.78 during midday trading on Friday, hitting $89.53. The company had a trading volume of 3,073,853 shares, compared to its average volume of 6,408,390. The business has a 50-day simple moving average of $95.67 and a two-hundred day simple moving average of $97.09. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The firm has a market capitalization of $6.82 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.